Advancing the manufacture of KSMs, APIs, Formulations, and Excipients for Resilient Industry Growth.
Mumbai platform to support India’s journey toward self-reliance with focused sectors: APIs, KSMs, formulations, and excipients.
MUMBAI, INDIA: Messe Muenchen India, in collaboration with the Indian Drug Manufacturers’ Association (IDMA), has announced PharmaCore India 2026, a dedicated trade fair focused on further strengthening India’s pharmaceutical sector. Scheduled to be held from 22-24 April 2026 at Jio Convention Centre in Mumbai, the event will serve as West India’s only strategic marketplace for critical pharmaceutical segments — APIs, formulations, chemicals, and excipients.
PharmaCore India 2026 draws on the combined experience of Messe Muenchen India (MMI), a leading organizer of trade fair events, and the Indian Drug Manufacturers’ Association (IDMA), a longstanding advocate for high-quality, local pharmaceutical manufacturing. This joint initiative is designed to complement the existing industry landscape, offering a space for collaboration, dialogue, and progress in new and existing product pipelines. While India has rightfully earned its reputation as the “pharmacy of the world,” there remains an ongoing need to advance domestic KSM and API capabilities and reduce import reliance.
Highlighting the purpose of this initiative, Bharat N Shah, National President of IDMA, stated: “PharmaCore India is a step towards addressing some of the sector’s priorities. By focusing on KSMs, APIs, formulations, and excipients, our aim is to provide members and stakeholders with an opportunity to strengthen supply chains, foster innovation, and exchange knowledge to support industry growth.”
Mumbai is the ideal venue for the launch of PharmaCore India 2026, blending industry leadership, regulatory access, and international trade. The city’s concentration of top pharmaceutical companies, advanced infrastructure, and direct links to government and global buyers make it the perfect place for meaningful partnerships and impactful industry engagement.
Bhupinder Singh, President IMEA, Messe Muenchen and CEO of Messe Muenchen India, highlighted the event’s role as a comprehensive ecosystem addressing the sector’s critical challenges. “PharmaCore India, in collaboration with IDMA, is designed to create an open and collaborative environment for West India’s pharmaceutical sector. By bringing together leading manufacturers, innovators, and stakeholders, we aim to foster regional progress in APIs, formulations, and chemical inputs—facilitating industry partnerships, supporting shared growth, and advancing the sector in meaningful ways.”
Pharmacore India – Key Highlights
- Focused Showcase: Dedicated to KSMs, APIs, formulations, and excipients — the core of pharma manufacturing.
- Investment & Innovation Hub: Investor–Startup Forum to connect innovators, ingredient specialists, and investors.
- Strategic Location: Hosted in Mumbai, the nerve centre for pharmaceutical corporates, regulators, and exporters.
- Global Gateway: Platform to forge international sourcing, trade partnerships, and supply chain collaborations.
- Co-located with analytica Lab India: Being held alongside South Asia’s biggest laboratory and analytical technology fair, attendees will have unique access to both pharmaceutical and lab industry communities at a single venue in Mumbai.
PharmaCore India 2026 aims to create a more integrated, resilient, and innovation-driven pharma ecosystem in India by addressing supply chain gaps, fostering collaboration, and enabling sustainable growth.
About Messe Muenchen India
Established in 2007 as a wholly owned subsidiary of Messe München GmbH, Messe Muenchen India is one of the leading B2B trade fair organizers in the IMEA (India, Middle East & Africa) region. The company brings together global and regional stakeholders through high-impact trade shows across key industry verticals. Its diverse portfolio includes events such as bauma CONEXPO INDIA, electronica India, productronica India, Gujarat CONEX, IFAT India, IFAT Africa, analytica Lab India in Mumbai & Hyderabad, analytica Lab Africa, SmartTech Asia, Laser World of Photonics India, The smarter E India, air cargo India, air cargo Africa, transport logistic Africa, PackMach Asia Expo, Pharma Pro&Pack Expo – Hyderabad, drinktec India, Indian Ceramics Asia, World Tea & Coffee Expo and transport logistic India. With its expansive reach and deep industry networks, Messe Muenchen India serves as a strategic platform for enabling business growth, investment, innovation, and cross-border collaboration across some of the most dynamic markets in the world.
About the Indian Drug Manufacturers’ Association (IDMA)
Established in 1961, IDMA is the apex national body representing over 1,000 small, medium, and large- scale pharmaceutical and API manufacturers across India through its eight state boards. Widely regarded as the “Voice of the National Sector”, IDMA works closely with the Government of India on critical issues including pricing, regulatory affairs, and policy advocacy, while actively promoting the production of affordable, high-quality medicines for India and the world. Beyond representation, IDMA drives industry growth through training programs, workshops, and global quality compliance initiatives in collaboration with leading institutions and regulatory bodies. With a legacy of championing self- reliance, fostering excellence, encouraging R&D and Innovation, with an emphasis on IPR, while actively supporting CSR initiatives. IDMA continues to play a pivotal role in strengthening India’s pharmaceutical sector and advancing its position as the pharmacy of the world.
